Cme Group annual debt-to-ebitda ratio
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cme Group Debt-to-EBITDA Ratio Growth & History (CME)
Cme Group's debt-to-ebitda ratio was 0.87 for fiscal 2025.
View full Cme Group company overviewCme Group annual debt-to-ebitda ratio history
| Fiscal year | Period ended | Debt-to-EBITDA ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.87 | −0.08 | −8.26% |
| 2024 | 2024-12-31 | 0.94 | −0.15 | −13.40% |
| 2023 | 2023-12-31 | 1.09 | −0.16 | −12.97% |
| 2022 | 2022-12-31 | 1.25 | −0.19 | −13.07% |
| 2021 | 2021-12-31 | 1.44 | −0.02 | −1.22% |
| 2020 | 2020-12-31 | 1.46 | −0.14 | −8.90% |
| 2019 | 2019-12-31 | 1.60 | −0.01 | −0.77% |
| 2018 | 2018-12-31 | 1.61 | 0.69 | +75.20% |
| 2017 | 2017-12-31 | 0.92 | −0.04 | −3.79% |
| 2016 | 2016-12-31 | 0.96 | −0.09 | −9.01% |
| 2015 | 2015-12-31 | 1.05 | −0.06 | −5.07% |
| 2014 | 2014-12-31 | 1.11 | −1.27 | −53.37% |
| 2013 | 2013-12-31 | 2.38 | 0.82 | +52.27% |
| 2012 | 2012-12-31 | 1.56 | 0.58 | +59.36% |
| 2011 | 2011-12-31 | 0.98 | −0.09 | −8.69% |
| 2010 | 2010-12-31 | 1.07 | −0.10 | −8.61% |
| 2009 | 2009-12-31 | 1.17 | −0.55 | −31.91% |
| 2008 | 2008-12-31 | 1.72 | — | — |
Cme Group quarterly debt-to-ebitda ratio
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-EBITDA ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.86 | −0.02 | −1.97% |
| Q1 2026 | 2026-03-31 | 0.82 | −0.08 | −8.97% |
| Q4 2025 | 2025-12-31 | 0.87 | −0.08 | −8.26% |
| Q3 2025 | 2025-09-30 | 0.88 | −0.09 | −8.96% |
| Q2 2025 | 2025-06-30 | 0.87 | −0.15 | −14.67% |
| Q1 2025 | 2025-03-31 | 0.91 | −0.17 | −15.71% |
| Q4 2024 | 2024-12-31 | 0.94 | −0.15 | −13.40% |
| Q3 2024 | 2024-09-30 | 0.97 | −0.18 | −16.00% |
| Q2 2024 | 2024-06-30 | 1.02 | −0.16 | −13.85% |
| Q1 2024 | 2024-03-31 | 1.07 | −0.16 | −12.63% |
| Q4 2023 | 2023-12-31 | 1.09 | −0.16 | −12.97% |
| Q3 2023 | 2023-09-30 | 1.16 | −0.12 | −9.11% |
| Q2 2023 | 2023-06-30 | 1.19 | −0.14 | −10.62% |
| Q1 2023 | 2023-03-31 | 1.23 | −0.14 | −10.22% |
| Q4 2022 | 2022-12-31 | 1.25 | −0.19 | −13.07% |
| Q3 2022 | 2022-09-30 | 1.27 | −0.27 | −17.31% |
| Q2 2022 | 2022-06-30 | 1.33 | −0.25 | −16.06% |
| Q1 2022 | 2022-03-31 | 1.37 | −0.23 | −14.52% |
| Q4 2021 | 2021-12-31 | 1.44 | −0.02 | −1.22% |
| Q3 2021 | 2021-09-30 | 1.54 | 0.21 | +16.09% |
| Q2 2021 | 2021-06-30 | 1.58 | 0.30 | +23.20% |
| Q1 2021 | 2021-03-31 | 1.60 | 0.28 | +21.08% |
| Q4 2020 | 2020-12-31 | 1.46 | −0.14 | −8.90% |
| Q3 2020 | 2020-09-30 | 1.32 | −0.28 | −17.54% |
| Q2 2020 | 2020-06-30 | 1.29 | −0.49 | −27.58% |
| Q1 2020 | 2020-03-31 | 1.32 | −0.53 | −28.53% |
| Q4 2019 | 2019-12-31 | 1.60 | −0.01 | −0.77% |
| Q3 2019 | 2019-09-30 | 1.61 | 0.29 | +22.47% |
| Q2 2019 | 2019-06-30 | 1.78 | 0.47 | +36.17% |
| Q1 2019 | 2019-03-31 | 1.85 | 0.98 | +112.40% |
| Q4 2018 | 2018-12-31 | 1.61 | 0.69 | +75.20% |
| Q3 2018 | 2018-09-30 | 1.31 | 0.39 | +42.73% |
| Q2 2018 | 2018-06-30 | 1.30 | 0.37 | +39.73% |
| Q1 2018 | 2018-03-31 | 0.87 | −0.08 | −8.12% |
| Q4 2017 | 2017-12-31 | 0.92 | −0.04 | −3.79% |
| Q3 2017 | 2017-09-30 | 0.92 | −0.07 | −6.95% |
| Q2 2017 | 2017-06-30 | 0.93 | −0.06 | −5.80% |
| Q1 2017 | 2017-03-31 | 0.95 | −0.07 | −6.97% |
| Q4 2016 | 2016-12-31 | 0.96 | −0.09 | −9.01% |
| Q3 2016 | 2016-09-30 | 0.99 | −0.07 | −6.65% |
| Q2 2016 | 2016-06-30 | 0.99 | −0.11 | −10.13% |
| Q1 2016 | 2016-03-31 | 1.02 | −0.44 | −30.22% |
| Q4 2015 | 2015-12-31 | 1.05 | −0.06 | −5.07% |
| Q3 2015 | 2015-09-30 | 1.06 | −0.14 | −11.92% |
| Q2 2015 | 2015-06-30 | 1.10 | −0.12 | −9.65% |
| Q1 2015 | 2015-03-31 | 1.46 | −0.85 | −36.81% |
| Q4 2014 | 2014-12-31 | 1.11 | −1.27 | −53.37% |
| Q3 2014 | 2014-09-30 | 1.20 | −0.37 | −23.34% |
| Q2 2014 | 2014-06-30 | 1.22 | −0.35 | −22.36% |
| Q1 2014 | 2014-03-31 | 2.31 | 0.71 | +44.15% |
| Q4 2013 | 2013-12-31 | 2.38 | 0.82 | +52.27% |
| Q3 2013 | 2013-09-30 | 1.57 | 0.02 | +1.07% |
| Q2 2013 | 2013-06-30 | 1.57 | 0.53 | +50.34% |
| Q1 2013 | 2013-03-31 | 1.60 | 0.59 | +58.40% |
| Q4 2012 | 2012-12-31 | 1.56 | 0.58 | +59.36% |
| Q3 2012 | 2012-09-30 | 1.55 | 0.60 | +63.02% |
| Q2 2012 | 2012-06-30 | 1.04 | 0.04 | +3.58% |
| Q1 2012 | 2012-03-31 | 1.01 | −0.00 | −0.46% |
| Q4 2011 | 2011-12-31 | 0.98 | −0.09 | −8.69% |
| Q3 2011 | 2011-09-30 | 0.95 | −0.15 | −13.90% |
| Q2 2011 | 2011-06-30 | 1.01 | −0.35 | −25.52% |
| Q1 2011 | 2011-03-31 | 1.02 | −0.60 | −37.13% |
| Q4 2010 | 2010-12-31 | 1.07 | −0.10 | −8.61% |
| Q3 2010 | 2010-09-30 | 1.10 | — | — |
| Q2 2010 | 2010-06-30 | 1.35 | — | — |
| Q1 2010 | 2010-03-31 | 1.62 | — | — |
| Q4 2009 | 2009-12-31 | 1.17 | — | — |
Cme Group debt-to-ebitda ratio trends
Over the last five fiscal years, Cme Group's debt-to-ebitda ratio decreased from 1.46 to 0.87, a change of −0.59. The latest reported quarter, Q2 2026, shows 0.86.
About the metric
What the debt-to-EBITDA ratio means
Debt-to-EBITDA compares interest-bearing debt with operating earnings before interest, taxes, depreciation, and amortization. It is commonly used to assess leverage, but it is generally unsuitable for banks and other financial companies.
Calculation and source
How debt-to-EBITDA is calculated
TickerStat divides period-end total debt by annual EBITDA. Quarterly observations use trailing-12-month EBITDA. Periods with zero or negative EBITDA are excluded because the leverage multiple would not be meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cme Group source filings ↗Community posts
CME plans European dairy futures and options through EEX transition
CME Group ($CME) agreed with the European Energy Exchange to transition EEX’s European dairy business, including its butter and skimmed-milk-powder indices, as EEX phases out those products. CME plans to establish its own European dairy ind ...
CME sets an FX open-interest record of 4.41 million contracts
CME Group reported a new foreign-exchange derivatives milestone on 7 September 2026. Reported records FX futures and options open interest reached 4,410,167 contracts on 4 September, exceeding the previous 4,269,622 record from 11 June. Tha ...